Campbell, Charles – Trademark Portfolio
Entity Type: 01
Campbell, Charles has 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include WDJT. The portfolio includes 1 registered trademark. Filings span 9 Nice Classification classes, led by Class 42 (Computer & Scientific) and Class 10 (Medical Apparatus). This trademark owner is based in Arlington, VA.
5945 10th Street North
Arlington, VA 22205
Showing of trademarks Trademarks
Trademark Classifications
Campbell, Charles's trademark portfolio spans 9 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Education; providing of training; entertainment; sporting and cultural activities
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does Campbell, Charles have?
Campbell, Charles has 11 U.S. trademarks filed with the USPTO. Of these, 1 registered, 7 abandoned, 3 cancelled.
What trademark classes does Campbell, Charles file in?
Campbell, Charles files trademarks across 9 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 25 (Clothing). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Campbell, Charles's most well-known trademarks?
Campbell, Charles's registered trademark portfolio includes well-known marks such as WDJT. These are among 1 currently registered trademark in the portfolio.
What is Campbell, Charles's trademark registration success rate?
Campbell, Charles has a 9% trademark registration rate, with 1 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.